These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 9264011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM.
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T, Saionji K, Hiejima Y, Hirayama H, Tago K, Takano H, Tajiri M, Hayashi K, Kawabata M, Funamizu M, Makita Y, Hata A.
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G.
    Gerontology; 2001 May; 47(6):324-9. PubMed ID: 11721146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients.
    Födinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Perschl A, Vychytil A, Hörl WH, Sunder-Plassmann G.
    Am J Kidney Dis; 2001 Jul; 38(1):77-84. PubMed ID: 11431185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P.
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J.
    Circulation; 1999 May 11; 99(18):2383-8. PubMed ID: 10318658
    [Abstract] [Full Text] [Related]

  • 14. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects.
    Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Lang T, Deecke L, Zeiler K.
    J Lab Clin Med; 1999 Jun 11; 133(6):575-82. PubMed ID: 10360632
    [Abstract] [Full Text] [Related]

  • 15. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS, Hung WR, Wei YH.
    Nephron; 2001 Mar 11; 87(3):249-56. PubMed ID: 11287760
    [Abstract] [Full Text] [Related]

  • 16. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I, Balla J, Szóke G, Bereczky Z, Páll D, Ben T, Toma K, Katona E, Mohácsi A, Paragh G, Varga Z, Kakuk G, Muszbek L.
    Orv Hetil; 2002 Jul 07; 143(27):1635-40. PubMed ID: 12180000
    [Abstract] [Full Text] [Related]

  • 17. Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease.
    Lee HA, Choi JS, Ha KS, Yang DH, Chang SK, Hong SY.
    Am J Kidney Dis; 1999 Aug 07; 34(2):259-63. PubMed ID: 10430972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG.
    Metabolism; 2003 Feb 07; 52(2):168-72. PubMed ID: 12601627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.